TEMODAL Capsules are indicated for the treatment of patients with: newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
TEMODAL Capsules are also indicated as first-line treatment for patients with advanced metastatic malignant melanoma.